Ceftobiprole:: breaking therapeutic dogmas of the β-lactam class

被引：7

作者：

Deresinski, Stanley C. ^{[1
,2
]}

机构：

[1] Stanford Univ, Med Ctr, San Jose, CA 94062 USA

[2] Santa Clara Valley Med Ctr, San Jose, CA 94062 USA

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2008年 / 61卷 / 01期

关键词：

Staphylococcus aureus; MRSA; antimicrobial; ceftobiprole; gram positive; gram negative; beta-lactam;

D O I：

10.1016/j.diagmicrobio.2008.02.011

中图分类号：

R51 [传染病];

学科分类号：

100401 [流行病与卫生统计学];

摘要：

[No abstract available]

引用

页码：82 / 85

页数：4

共 40 条

[1]

Andes D. R., 2005, PRINCIPLES PRACTICE, P294

[2]

[Anonymous], 2005, PRINCIPLES PRACTICE

[3]

Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis [J].

Bogdanovich, Tatiana ;

Clark, Catherine ;

Ednie, Lois ;

Lin, Gengrong ;

Smith, Kathy ;

Shapiro, Stuart ;

Appelbaum, Peter C. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (06) :2050-2057

[4]

Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center [J].

Bozdogan, B ;

Esel, D ;

Whitener, C ;

Browne, FA ;

Appelbaum, PC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) :864-868

[5]

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004 [J].

Cardo, D ;

Horan, T ;

Andrus, M ;

Dembinski, M ;

Edwards, J ;

Peavy, G ;

Tolson, J ;

Wagner, D .

AMERICAN JOURNAL OF INFECTION CONTROL, 2004, 32 (08) :470-485

[6]

*CDC, 1997, MMWR-MORBID MORTAL W, V46, P624

[7]

Ceftobiprole: in-vivo profile of a bactericidal cephalosporin [J].

Chambers, HF .

CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 :17-22

[8]

Clinical and Laboratory Standards Institute (CLSI), 2007, M100S17 CLSI, V27

[9]

Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus [J].

Daum, Robert S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (04) :380-390

[10]

Activities of ceftobiprole and other β-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x [J].

Davies, TA ;

Shang, WC ;

Bush, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) :2530-2532

← 1 2 3 4 →